Literature DB >> 12701740

High variability of perilymphatic entry of neutral molecules through the round window.

Larbi Chelikh1, Marie Teixeira, Christian Martin, Olivier Sterkers, Evelyne Ferrary, Vincent Couloigner.   

Abstract

OBJECTIVE: To improve the efficacy of intratympanic therapy using perilymphatic entry through the round window membrane.
MATERIAL AND METHODS: The perilymphatic entry characteristics of 2 neutral molecules, mannitol (182.2 Da) and inulin (7,000 Da), were studied. A polyethylene catheter was placed in contact with the guinea pig round window membrane and sealed with cyanoacrylate glue. This catheter was linked to an osmotic minipump that delivered 100 microl portions of 3H-mannitol or 3H-inulin solutions over a 7-day period at a constant rate (0.5 microl/h). Perilymph in the scala vestibuli and scala tympani, cerebrospinal fluid (CSF) and plasma were sampled after 4-7 days of delivery.
RESULTS: Despite the constant rate of infusion, perilymphatic radioactivity varied widely from one animal to the other, probably as a function of the position of the microcatheter within the round window niche and/or the permeability of the round window. Even a large molecule such as inulin entered the perilymphatic space. Seven days after the beginning of 3H-mannitol administration, the radioactivity was higher in the perilymph of the scala tympani than in that of the scala vestibuli. The perilymphatic radioactivity on Day 7 was approximately 50% lower than that measured on Day 4 (p = NS). Finally, round window membrane delivery did not preclude distant spread of the molecules into the blood and CSF.
CONCLUSIONS: Using round window membrane delivery, the perilymphatic entry of mannitol and inulin depended on their molecular weight. Intratympanic delivery induced a high inter-individual heterogeneity of the drug concentration within the inner ear, with subsequent variability of the therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12701740     DOI: 10.1080/00016480310001042

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  8 in total

1.  Intratympanic dexamethasone perfusion versus injection for treatment of refractory sudden sensorineural hearing loss.

Authors:  Lihua Li; Jihao Ren; Tuanfang Yin; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-06       Impact factor: 2.503

Review 2.  [Inquiries into local application of drugs on the inner ear. Innovation prize of the Working Group for German Speaking Audiologists and Neuro-otologists 2005].

Authors:  S Plontke
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

3.  Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.

Authors:  Hartmut Hahn; Bernd Kammerer; Andre DiMauro; Alec N Salt; Stefan K Plontke
Journal:  Hear Res       Date:  2006-01-25       Impact factor: 3.208

4.  Perilymph sampling from the cochlear apex: a reliable method to obtain higher purity perilymph samples from scala tympani.

Authors:  Alec N Salt; Shane A Hale; Stefan K R Plonkte
Journal:  J Neurosci Methods       Date:  2005-11-28       Impact factor: 2.390

5.  Marker retention in the cochlea following injections through the round window membrane.

Authors:  Alec N Salt; Davud B Sirjani; Jared J Hartsock; Ruth M Gill; Stefan K Plontke
Journal:  Hear Res       Date:  2007-06-27       Impact factor: 3.208

6.  Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing.

Authors:  Hongzhuo Liu; Liang Feng; Gaurav Tolia; Mark R Liddell; Jinsong Hao; S Kevin Li
Journal:  Drug Dev Ind Pharm       Date:  2013-04-30       Impact factor: 3.225

7.  Concentration gradient along the scala tympani after local application of gentamicin to the round window membrane.

Authors:  Stefan K Plontke; Robert Mynatt; Ruth M Gill; Stefan Borgmann; Alec N Salt
Journal:  Laryngoscope       Date:  2007-07       Impact factor: 3.325

8.  Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid and Epitympanic Obliteration Surgery: Prospective Clinical Study.

Authors:  Daniele Bernardeschi; Yann Nguyen; Francesca Yoshie Russo; Isabelle Mosnier; Evelyne Ferrary; Olivier Sterkers
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.